Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 8Withdrawn 2Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Colorectal Neoplasms 8Breast Neoplasms 8Esophageal Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Carcinoma, Hepatocellular 6Glioblastoma 5Brain Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Colonic Neoplasms 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Lymphatic Metastasis 3Glioma 3Endometrial Neoplasms 3Disease 3Astrocytoma 3Thyroid Neoplasms 2Recurrence 2Pain, Postoperative 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Etoposide 3Docetaxel 3ribociclib 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ipilimumab 2Immune Checkpoint Inhibitors 2Gene Expression Profiling 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Surgical Procedures, Operative × Clear all
NCT05602415 2022-11-02

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Ruijin Hospital

Phase 2 Unknown
41 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡